AstraZeneca has reported the first phase 3 data with its next-generation complement C5 inhibitor, gefurulimab, which could give patients with generalised myasthenia gravis (gMG) a treatment option ...
Eli Lilly has raised the stakes in its rivalry with Novo Nordisk on GLP-1 agonists for diabetes, with new data for Mounjaro on cardiovascular outcomes. The results of the SURPASS-CVOT trial showed ...
Dave Douglas is a prolific trumpeter, composer, and educator from New York City known for the stylistic breadth of his work, the lyricism and wide-ranging curiosity of his music, and for keeping a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results